Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adeno-Associated Virus Serotype 1 (AAV1)- and AAV5-Antibody Complex Structures Reveal Evolutionary Commonalities in Parvovirus Antigenic Reactivity

20 Nov 2014

Abstract excerpt

UNLABELLED: The clinical utility of the adeno-associated virus (AAV) gene delivery system has been validated by the regulatory approval of an AAV serotype 1 (AAV1) vector for the treatment of lipoprotein lipase deficiency. However, neutralization from preexisting antibodies is detrimental to AAV transduction efficiency. Hence, mapping of AAV antigenic sites and engineering of neutralization-escaping vectors are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Pluripotent Stem Cells Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25410874
DOI: 10.1128/jvi.02710-14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adeno-Associated Virus Serotype 1 (AAV1)- and AAV5-Antibody Complex Structures Reveal Evolutionary Commonalities in Parvovirus Antigenic ReactivityPMID 25410874Read ↗

Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common RegionsSemantic proximity Read ↗

High-Resolution Structural Characterization of a New Adeno-associated Virus Serotype 5 Antibody Epitope toward Engineering Antibody-Resistant Recombinant Gene Delivery VectorsSemantic proximity Read ↗

Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8Semantic proximity Read ↗

Adeno-associated virus (AAV) cell entry: structural insightsSemantic proximity Read ↗

Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohortsSemantic proximity Read ↗

Adeno-Associated Virus Structural Biology as a Tool in Vector DevelopmentSemantic proximity Read ↗

Structural characterization of antibody-responses from Zolgensma treatment provides the blueprint for the engineering of an AAV capsid suitable for redosingSemantic proximity Read ↗

Structure of Adeno-Associated Virus Serotype 5Semantic proximity Read ↗

Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasionSemantic proximity Read ↗

Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehiclesSemantic proximity Read ↗

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralizationSemantic proximity Read ↗

Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVRSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.